Intensity Therapeutics to Present Preliminary Data from Clinical Study of INT230-6 at Upcoming Medical Conferences
Posters at European Society for Medical Oncology (ESMO) 2018 Congress and Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting to highlight safety of intratumoral INT230-6 in patients with advanced solid tumorsWESTPORT, Conn., Oct. 17, 2018 ( …